相关实验视频
Updated: Jul 20, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
一个个性化的方法来管理库辛病的管理
Maria Fleseriu1,2,3, Elena V Varlamov4, Jose M Hinojosa-Amaya5
1Department of Medicine, Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, OR, USA. fleseriu@ohsu.edu.
Nature reviews. Endocrinology
|August 3, 2023
概括
库希氏病是由ACTH分泌的垂体瘤驱动的,这给诊断和管理带来了挑战. 早期诊断和量身定制的治疗对于改善患者的结果和降低死亡率至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 神经外科 神经外科
背景情况:
- 库希病是由ACTH分泌的垂体腺瘤引起的,导致高皮质血和显著的死亡率.
- 由于异质症状和生化测试的局限性,诊断是复杂的.
- 垂体腺瘤通常很小,MRI可能无法检测到.
研究的目的:
- 审查成年人诊断和管理库辛病的挑战.
- 为综合和个性化的患者管理方法提供指导.
主要方法:
- 对包括唾液皮质醇,尿液自由皮质醇和甲抑制测试在内的诊断测试的审查.
- 讨论像MRI和黄金标准等成像模式,下层状鼻采样.
- 治疗选择概述:跨形外科手术,药物治疗,垂体辐射和双侧上腺切除术.
主要成果:
- 下垂鼻腔采样是确认垂体ACTH分泌的黄金标准.
- 转腺瘤切除是主要的治疗方法,在某些地区使用手术前的药物治疗.
- 管理需要用药物,辐射或上腺切除术来解决持续或复发的疾病.
结论:
- 终身监测对于并发症,复发和治疗副作用至关重要.
- 为了有效管理库辛病,需要采用综合和个性化的方法.
- 解决诊断和治疗方面的挑战是改善患者生存率和生活质量的关键.
相关概念视频
Adrenal Gland Disorders
1.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.6K
Diabetes: Management and Pharmacotherapy
311
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
311
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K

